Neuren drug finally been cleared by FDA in USA
SYDNEY: Australia’s top performing health stock for 2022, Neuren, has gained clearance from the US
SYDNEY: Australia’s top performing health stock for 2022, Neuren, has gained clearance from the US
FEATURED
French lessons in art of urban regeneration show ‘People come first’
Couple takes on new adventure as caretakers of the island
High-end private assisted living facility set to be developed
Council set to consider proposal to house elderly farmworkers
Group of finance partners launch new loan program for assisted living
Over-50s facing job hunt agony as deemed to old to hire
INNOVATION
